Our understanding of the gut microbiota has significantly evolved over the last two decades. Advances in the analysis of the gut microbiome continues to reveal complex microbial communities and discoveries about their role in health and diseases, including cancer development, are continuously growing. In addition, research has demonstrated that the use of antibiotics can modulate the gut microbiota composition negatively and influence cancer treatment outcomes, suggesting that antibiotics should be avoided if possible. In this article, we review the role of the gut microbiota in the formation of GI cancers. We show that specific bacterial populations can positively or negatively affect cancer formation with specific attention given to gastric and colorectal cancer. We also review the role of microbial-targeted therapies on cancer treatment outcomes.
Antibiotics, the microbiome and gastrointestinal cancers: a causal interference? / Ramai, Daryl; Salati, Massimiliano; Pomati, Giulia; Amoroso, Chiara; Facciorusso, Antonio; Botticelli, Andrea; Ghidini, Michele. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4973. - 67:(2022). [10.1016/j.coph.2022.102315]
Antibiotics, the microbiome and gastrointestinal cancers: a causal interference?
Pomati, Giulia;Botticelli, AndreaPenultimo
;
2022
Abstract
Our understanding of the gut microbiota has significantly evolved over the last two decades. Advances in the analysis of the gut microbiome continues to reveal complex microbial communities and discoveries about their role in health and diseases, including cancer development, are continuously growing. In addition, research has demonstrated that the use of antibiotics can modulate the gut microbiota composition negatively and influence cancer treatment outcomes, suggesting that antibiotics should be avoided if possible. In this article, we review the role of the gut microbiota in the formation of GI cancers. We show that specific bacterial populations can positively or negatively affect cancer formation with specific attention given to gastric and colorectal cancer. We also review the role of microbial-targeted therapies on cancer treatment outcomes.File | Dimensione | Formato | |
---|---|---|---|
Ramai_Antibiotics_2022.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
521.02 kB
Formato
Adobe PDF
|
521.02 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.